Filed: 8/12/2025ACC: 0001104659-25-076815
📋 What this filing means
FORESITE CAPITAL MANAGEMENT IV, LLC filed this quarterly 13F‑HR report disclosing 6 equity positions with a total reported market value of $123.80M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
6
Positions
$123.80M
Total AUM (reported)
9.30M
Total Shares
Allocation by class
COM$123.80M100.0%
Portfolio Concentration
Top 3$110.61M89.4%
4–10$13.18M10.6%
Top 3 weight
89.4%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 9.30M
Sole
Full voting authority
9.30M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole6
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings6
Rows:
Pharvaris N.V.
SOLEShares4.41M
TypeSH
Market value$77.63M
62.70%
Sole
4.41M
Shared
0.00
None
0.00
Maze Therapeutics Inc
SOLEShares2.11M
TypeSH
Market value$25.91M
20.93%
Sole
2.11M
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares800.40K
TypeSH
Market value$7.08M
5.72%
Sole
800.40K
Shared
0.00
None
0.00
Xenon Pharmaceuticals Inc
SOLEShares160K
TypeSH
Market value$5.01M
4.05%
Sole
160K
Shared
0.00
None
0.00
Kura Oncology, Inc.
SOLEShares816.88K
TypeSH
Market value$4.71M
3.81%
Sole
816.88K
Shared
0.00
None
0.00
Relay Therapeutics Inc.
SOLEShares1M
TypeSH
Market value$3.46M
2.79%
Sole
1M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Pharvaris N.V.SOLE | COM | 4.41M | SH | $77.63M 62.70% | 4.41M | 0.00 | 0.00 |
Maze Therapeutics IncSOLE | COM | 2.11M | SH | $25.91M 20.93% | 2.11M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 800.40K | SH | $7.08M 5.72% | 800.40K | 0.00 | 0.00 |
Xenon Pharmaceuticals IncSOLE | COM | 160K | SH | $5.01M 4.05% | 160K | 0.00 | 0.00 |
Kura Oncology, Inc.SOLE | COM | 816.88K | SH | $4.71M 3.81% | 816.88K | 0.00 | 0.00 |
Relay Therapeutics Inc.SOLE | COM | 1M | SH | $3.46M 2.79% | 1M | 0.00 | 0.00 |